Clinical Study

2017C0128 Optec- Universal Screening For Dna Mismatch Repair Deficiency And Personalized Cancer Treatment

Posted Date: Feb 5, 2020

  • Investigator: Caroline Billingsley
  • Specialties: Cancer, Oncology
  • Type of Study: Observational/Survey

The purpose of this screening program is 1. Molecular classification of tumor abnormalities through innovative upfront next-generation sequencing. 2. Comprehensive approach to genetic risk assessment and management.

Criteria:

Adult Women Who Had A Hysterectomy Or Diagnostic Biopsy Proving A Newly Diagnosed Endometrial Adenocarcinoma (Any Stage) Between 10/1/2017 And 4/30/2020, Adult Relatives Of The Ec Patients Found To Have Ls.

Keywords:

Cancer, Dna Screening

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.